Barely Significant
← all excerpts

Therapeutic effects of Kangxian Yanshen formula on patients with chronic kidney disease stages 3-4: a retrospective cohort study.

Front Med (Lausanne) · 2024 · PMC11458470 · PMID 39380733

3
hedged sentences
closest p
boldest claim

The sentences

an increasing trendno p-value reported
All showed an increasing trend at months 24 and 36, with the magnitude of change in the 24-hour proteinuria difference being most pronounced at month 24 (Kangxian Yanshen Formula group: Δ0.21 [± 0.92 SD] g/d versus Western medicine group: Δ0.41 [± 1.59 SD] g/d; between-group difference Δ−0.45 g/d; P = 0.021).

also in 63,971 other papers

a decreasing trendno p-value reported
Participants in both groups showed a decreasing trend in eGFR at months 24 and 36.

also in 47,180 other papers

showed a trendno p-value reported
Serum creatinine remained almost constant among participants in the Kangxian Yanshen Formula group, whereas participants in the Western medicine group showed a trend toward a significant increase in serum creatinine.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.